Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,338,000 | 4,104,000 | 3,163,000 | 3,514,000 | 5,534,000 |
| Marketable Securities | 69,000 | 67,000 | 64,000 | 65,000 | 66,000 |
| Inventories | 4,231,000 | 4,274,000 | 4,111,000 | 4,093,000 | 3,900,000 |
| Other current assets | 5,751,000 | 6,416,000 | 6,215,000 | 5,573,000 | 5,727,000 |
| TOTAL | $14,678,000 | $14,861,000 | $13,553,000 | $13,245,000 | $15,227,000 |
| Non-Current Assets | |||||
| PPE Net | 9,052,000 | 8,828,000 | 8,667,000 | 8,803,000 | 8,872,000 |
| Intangibles | 12,044,000 | 12,103,000 | 12,079,000 | 13,219,000 | 13,488,000 |
| Other Non-Current Assets | 4,877,000 | 4,511,000 | 4,551,000 | 4,440,000 | 4,499,000 |
| TOTAL | $25,973,000 | $25,442,000 | $25,297,000 | $26,462,000 | $26,859,000 |
| Total Assets | $40,651,000 | $40,303,000 | $38,850,000 | $39,707,000 | $42,086,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,915,000 | N/A | N/A | N/A | 2,762,000 |
| Accounts payable and accrued liabilities | 2,790,000 | 7,541,000 | 6,949,000 | 7,300,000 | 2,739,000 |
| TOTAL | $13,295,000 | $15,270,000 | $12,252,000 | $11,667,000 | $13,677,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,784,000 | N/A | N/A | N/A | 15,403,000 |
| Other Non-Current Liabilities | 5,461,000 | 17,943,000 | 18,346,000 | 19,109,000 | 3,633,000 |
| TOTAL | $22,420,000 | $19,283,000 | $19,762,000 | $20,609,000 | $20,597,000 |
| Total Liabilities | $35,715,000 | $34,553,000 | $32,014,000 | $32,276,000 | $34,274,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,339,000 | 1,338,000 | 1,338,000 | 1,337,000 | 1,336,000 |
| Retained earnings | -2,074,000 | -1,190,000 | -158,000 | 478,000 | 913,000 |
| Other shareholders' equity | 2,239,000 | 2,178,000 | 2,232,000 | 2,126,000 | 2,153,000 |
| TOTAL | $4,263,000 | $5,043,000 | $6,118,000 | $6,616,000 | $6,997,000 |
| Total Liabilities And Equity | $39,978,000 | $39,596,000 | $38,132,000 | $38,892,000 | $41,271,000 |